| Market Cap | ₹22,794Cr |
| ROE | 18.36% |
| P/E Ratio(TTM) | 27.16 |
| EPS(TTM) | 183.46 |
| P/B Ratio | 5.92 |
| Dividend Yield | 3.31% |
| Industry P/E | 39.71 |
| Book Value | 841.20 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
| Parent Organisation | Pfizer Limited |
| Managing Director | Meenakshi Nevatia |
| Founded | 1950 |
| NSE Symbol | PFIZER |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 40.94 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 43.82 | ||
| Astrazeneca Pharma India | NA (0.00%) | 113.11 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 47.84 |